TABLE 3

Mean scores (sd) of anxiety (GAD-7), depression (PHQ-9) and health-related quality of life (QOL-PCD), in adults, adolescents and children with PCD and caregivers (n=103)

Adults with PCD (n=33)Adolescents with PCD (age 12–17 years, n=17)Children with PCD (age 6–11 years, n=7)Mothers (n=24)Fathers (n=22)
Mean(sd)Mean(sd)Mean(sd)Mean(sd)Mean(sd)
Anxiety (GAD-7)#4.3(3.1)5.4(2.9)3.0(4.4)6.2(6.2)3.0(3.3)
Depression (PHQ-9)5.6(4.2)5.5(3.5)3.6(4.2)5.4(4.7)3.1(3.8)
Health-related quality of life (QOL-PCD) domains
 Physical Functioning65.3(29.2)87.5(15.0)84.8(14.8)
 Emotional Functioning81.9(13.1)73.4(7.6)76.2(13.1)
 Social Functioning34.7(27.0)62.5(19.7)91.4(10.7)
 Treatment Burden60.9(23.2)74.8(22.4)80.0(26.1)
 Role Functioning66.2(25.4)86.8(15.3)
 Vitality55.9(19.3)60.4(14.6)
 Health Perceptions50.8(22.6)
 Upper Respiratory Symptoms55.1(21.6)69.6(19.3)75.2(17.5)
 Lower Respiratory Symptoms51.3(18.7)58.9(19.1)73.0(10.4)
 Hearing Symptoms68.2(32.9)83.9(18.1)86.9(10.6)

PCD: primary ciliary dyskinesia; GAD-7: Generalised Anxiety Disorder 7-Item; PHQ-9: Patient Health Questionnaire-9; QOL-PCD: Quality of Life Instrument for Primary Ciliary Dyskinesia. #: Scores (0–21), scores ≥10 are considered clinically elevated. : Scores (0–27), scores ≥10 are considered clinically elevated.